Loading…
Sanjivani Paranteral (BSE 531569)₹173.85−1.64%Pharmaceuticals
Sanjivani Paranteral is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 28.8 against a peer median of 22.1, and ROCE of 18.0% against a peer median of 11.1%, and latest-quarter sales growth of 33.3% against a peer median of 16.5%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BDH Industries | 240 | 22.1 | 19.9 | 14.8 | 0.03 | 1.2 | 96 | 11 | 62.8 | 15.6 | vs BSE 531569 |
| Zenotech Laboratories | 238 | — | 4.6 | −1.2 | 0.00 | 0.0 | 44 | −1 | 10.2 | −145.0 | vs BSE 531569 |
| Accretion Nutraveda | 237 | 47.2 | 27.8 | 25.1 | 0.12 | 0.0 | 34 | 5 | 80.4 | 56.1 | vs BSE 531569 |
| Accretion Pharmaceuticals | 225 | 23.3 | 28.9 | 27.6 | 0.23 | 0.0 | 89 | 10 | 18.2 | 13.9 | vs BSE 531569 |
| Gennex Laboratories | 218 | 11.2 | 11.0 | 9.2 | 0.36 | 0.0 | 173 | 21 | 16.5 | −6.8 | vs BSE 531569 |
| Sanjivani Paranteral | 214 | 28.8 | 18.0 | 15.6 | 0.30 | 0.3 | 69 | 7 | 33.3 | 44.2 | — |
| Kerala Ayurveda | 212 | — | −10.0 | −161.1 | 7.83 | 0.0 | 131 | −16 | 15.9 | −500.5 | vs BSE 531569 |
| Nectar Lifesciences | 198 | — | 0.0 | −31.3 | 0.00 | 0.0 | 0 | −293 | −100.0 | — | vs BSE 531569 |
| Achyut Healthcare | 195 | — | 1.2 | 1.0 | 0.01 | — | 12 | 0 | 381.3 | −46.2 | vs BSE 531569 |
| Brooks Laboratories | 194 | 14.7 | 21.1 | 22.1 | 0.07 | 0.0 | 86 | 25 | −10.0 | −118.6 | vs BSE 531569 |
| Coral Laboratories | 192 | 11.6 | 11.1 | 7.9 | 0.02 | 0.3 | 86 | 16 | −5.8 | 84.8 | vs BSE 531569 |
| Peer median | 214 | 22.1 | 11.1 | 9.2 | 0.07 | 0.0 | 86 | 7 | 16.5 | 3.6 |
Listed companies closest to Sanjivani Paranteral in Pharmaceuticals include BDH Industries, Zenotech Laboratories, Accretion Nutraveda, Accretion Pharmaceuticals, Gennex Laboratories, Kerala Ayurveda, Nectar Lifesciences, Achyut Healthcare.
BDH Industries, with a market cap of ₹240 Cr.
Sanjivani Paranteral trades at a P/E of 28.8; the median of its peer set is 22.1. A P/E above or below the median is a description, not a judgement on value.
Sanjivani Paranteral's return on capital employed is 18.0%, above the peer median of 11.1%.